INTRODUCTION
============

Spinal and spinal nervous diseases are some of the most frequently encountered problems in clinical medicine \[[@b1-ns-1836038-019]\]. Lower back pain affects up to 80% of the global population at some point in life, and 1% to 2% of the United States adult population is disabled due to lower back pain \[[@b1-ns-1836038-019],[@b2-ns-1836038-019]\]. Back and neck pain are 2 of the most common reasons for visits to primary care physicians in the United States and cause considerable disability and financial burden \[[@b3-ns-1836038-019]\]. Similar to the existing trend in the Republic of Korea (ROK), the incidence of disc herniation was the highest globally in 2014 \[[@b4-ns-1836038-019]\]. Moreover, degenerative spinal diseases are also increasing in incidence as the average life span increases \[[@b5-ns-1836038-019]\]. Although most spinal diseases are not fatal, their associated morbidity exerts an enormous toll from both personal and societal perspectives \[[@b3-ns-1836038-019]\]. The substantial medical needs of affected patients, coupled with our poor understanding of the epidemiology of spinal diseases, have led to an ever-expanding array of medical costs and treatment options \[[@b6-ns-1836038-019],[@b7-ns-1836038-019]\]. The estimated direct total medical expenditure in the United States for spinal care in 2006 was more than \$85 billion, and the data suggest that the use and costs of spine care have been increasing at an alarming rate in recent years \[[@b7-ns-1836038-019]\].

Despite the vast amount of research devoted to spinal diseases, the epidemiology of this condition is not well understood, and the overall prevalence is unclear in many countries, even in the United States \[[@b7-ns-1836038-019],[@b8-ns-1836038-019]\]. The ROK has a National Health Insurance Service (NHIS), which is a compulsory social insurance system that insures approximately 97% of the population \[[@b9-ns-1836038-019]\]. The majority of remaining 3% of population is covered by Medical Aid \[[@b9-ns-1836038-019]\]. All hospitals and clinics in the ROK submit medical records including diagnosis and operation codes of patients covered by the NHIS or Medical Aid to a Health Insurance Review & Assessment Service (HIRA) for review to be reimbursed for any healthcare services provided \[[@b9-ns-1836038-019]\]. The HIRA database nationally representative and contains data on multiple variables important to epidemiological research, such as diagnosis, treatment, procedures performed, surgical history, and treatment prescriptions.

The goals of this study were to describe the incidence and analyze trends related to spinal diseases based on a nationwide database in the ROK and to elucidate the health care burden for researchers, clinicians, patients, and families. Additionally, we aimed to investigate the distribution of medical expenses based on sex, age, and diagnostic code associated with spinal diseases.

MATERIALS AND METHODS
=====================

This study involved a retrospective analysis of data obtained from Healthcare Bigdata Hub, the Korean Statistical Information Service (KOSIS), and Open Data Portal from 2012 through 2016. The Healthcare Bigdata Hub, KOSIS, and Open Data Portal are maintained by the HIRA, Statistics Korea, and Ministry of the Interior and Safety, respectively. These databases include records of all patients who receive care at all Korean hospitals and clinics, and medical costs based on disease codes, age, and sex. The database included the beneficiaries of the NHIS and did not included population of Medical Aid. The data were acquired by disease codes according to the Korean Standard Classification of Diseases, seventh edition \[[@b10-ns-1836038-019]\] as same as the International Classification of Diseases, Tenth Revision (ICD-10) \[[@b11-ns-1836038-019]\].

1. Inclusion and Exclusion Criteria
-----------------------------------

We identified patients with spinal diseases and classified them according to the following ICD-10 codes for spinal diseases: deforming dorsopathy (M40--43), spondylopathy (M45--49), and other dorsopathy (M50--54) ([Table 1](#t1-ns-1836038-019){ref-type="table"}). Data for patients treated with these disease codes as a main diagnosis were included in this study. Patients diagnosed with these disease code as an accessory diagnosis were not included. Patients with spinal diseases due to congenital disease or trauma were excluded. The entire population data of the ROK were imported from the KOSIS census data to calculate the proportions of patients treated with spinal diseases relative to the entire population.

2. Data Variables
-----------------

The total medical expenditure of beneficiaries of the NHIS in the ROK comprises paid medical expenses by insurers, copayments, unpaid medical expenses by insurers, and pharmacy preparation costs from pharmaceutical prescriptions. Copayments are paid by beneficiaries in addition to payments made by insurers, and made up 5%--20% of the total costs of items covered by the NHIS. Unpaid medical expenses by insurers are costs of devices or services which are not covered by the NHIS, and are paid by the patients themselves. Medication costs are shared between the insurer and the beneficiary, with the beneficiary paying 30%--50% of the medication cost.

Medical expenditure was calculated in Korean won (KRW, ), and converted to United States dollars (USD, \$) using the average exchange rate from 2012 to 2016. We tried to demonstrate the costs in both USD and KRW. Otherwise, the standard unit of cost in this study was \$, and the raw data for KRW are described in [Supplementary Table 1](#SD1-ns-1836038-019){ref-type="supplementary-material"}.

3. Analysis
-----------

The statistical analysis was mainly descriptive to determine the annual trends in the number and cost of spinal diseases as well as the differences in age, sex, and disease code distributions. Chi-square tests were used to identify any differences in the distribution of numbers and costs by age, sex, and disease code. A p-value of \<0.05 was regarded to be significant. Counts, means, rates, ratios, proportions, and other relevant statistics were calculated using R 3.4.3 (R Foundation for Statistical Computing, Vienna, Austria) and/or Microsoft Excel 2016 (Microsoft Corporation, Redmond, DC, USA).

RESULTS
=======

1. Number of Patients With Spinal Diseases
------------------------------------------

Annually, 7,985,929 patients (men, 3,317,868; women, 4,668,061) among the 52 million of total population in the ROK were diagnosed with spinal diseases during the study period. The overall annual incidence rate of spinal diseases per 100,000 population was 15,743 (men, 13,042; women, 18,460) from 2012 through 2016 in the ROK; their trends are presented in [Fig. 1](#f1-ns-1836038-019){ref-type="fig"}. Over the study period, the annual incidence rate of spinal diseases rose continuously from 15,228 per 100,000 population in 2012 to 16,387 in 2016, which represents an increase of 7.6% over 5 years. Spinal diseases were more frequent among women than among men during the study period, and the sex ratio was 1:1.41 in 2014 (p\<0.01). The annual sex ratio of spinal diseases changed from 1:1.46 to 1:1.38, suggesting a decrease in the incidence of spinal diseases among women over that period.

The incidence rate of spinal diseases based on age distribution is shown in [Table 2](#t2-ns-1836038-019){ref-type="table"}. During the study period, there was no significant difference in the incidence across the years. In 2016, spinal diseases were the most common in the late 50s (55--59 years) age group ([Fig. 2A](#f2-ns-1836038-019){ref-type="fig"}). There were 1,586 men and 2,483 women per 100,000 population diagnosed with spinal diseases in that age group. Considering the age distribution of the population in the ROK, the age-adjusted incidence rate of which denominator is the population of same sex and age group in the ROK increased with age ([Fig. 2B](#f2-ns-1836038-019){ref-type="fig"}). The age-adjusted incidence rate increased rapidly in the 25--29, 50--54, and 65--69 years age groups. The age group with the highest incidence of spinal disease was the 75--79 years age group, with incidences of 42,580 (42.6%) per 100,000 population. The peak incidence rate stratified by sex and age group was 36,206 (36.2%) among men and 48,953 (49.0%) among women in the 75--79 years age group per 100,000 population of the same sex and age group.

Among 15,877 patients, the median annual incidence per 100,000 population, patients older than 65 years old was 4,969 (31.0%), which increased continuously ([Table 3](#t3-ns-1836038-019){ref-type="table"}). During the study period, proportion of the age (≥ 65 years old) group among the entire population in the ROK increased from 11% through 12.7%. The annual incidence in the age group per 100,000 population of the same age (≥ 65 years old) group was 42,289 in 2012 and 40,897 in 2016, which demonstrated age adjusted incidence rate did not increased.

2. The Distribution of Patients With Spinal Diseases Stratified by Disease Code, Age, and Sex
---------------------------------------------------------------------------------------------

The distribution of patients with spinal diseases stratified by disease code is shown in [Fig. 3](#f3-ns-1836038-019){ref-type="fig"}. The most frequently reported disease code was dorsalgia (M54), followed by thoracic, thoracolumbar, and lumbosacral intervertebral disc disorders (M51), other spondylosis including spinal stenosis and ankylosing hyperostosis (M48), spondylosis (M47), cervical disc disorders (M50), other dorsopathies, not elsewhere classified (M53), and other deforming dorsopathies including spondylolisthesis and recurrent atlantoaxial subluxation (M43). The incidence ranking did not change substantially over the 5 years. M54 including radiculopathy, sciatica, back pain, and dorsalgia was the most common disease code and a symptom related code, and was usually used as a preliminary diagnosis before diagnostic workup. M51, including lumbar disc herniation was the second most common disease.

In 2016, the distribution of spinal diseases by disease code (ICD-10) and sex is depicted in [Fig. 4](#f4-ns-1836038-019){ref-type="fig"}. Among all the patients with spinal disease, the ranking of the top 5 conditions regarding incidence rate by patient number was the same in both sexes. Spinal diseases were more frequent among men younger than 39 years, and among women older than 40 years. Among children and adolescents aged 0--19 years, deforming dorsopathy (M40--43) was more common than that observed in other age groups. Among those younger than 59 years, disc herniation and radiculopathy (M51 and M54) was the most common regardless of sex. Among those older than 60 years, spinal stenosis and radiculopathy (M48 and M54) were the most common code for both sexes. Among patients at least 50 years of age, the incidence of spondylopathy including spinal stenosis (M45--49), increased rapidly with increasing age, while that of herniated discs (M50--54) decreased ([Table 4](#t4-ns-1836038-019){ref-type="table"}).

3. Medical Expenditure for Spinal Diseases
------------------------------------------

The mean annual medical cost per patient for spinal diseases rose continuously from \$216.66 (248,080) in 2012 to \$248.62 (284,660) in 2016, which represents a 14.7% increase over 5 years ([Fig. 5](#f5-ns-1836038-019){ref-type="fig"}). The medical costs for male and female patients increased by 13.9% and 15.4% over the 5 years, respectively. Male and female patients visited the clinic or hospital on an average of 6.25 and 7.45 times per year, respectively (p=0.74). Proportion of medical expenditure of patients older than 65 years old increased from 38.6% (men, 32.2%; women, 42.9%) in 2012 to 41.2% (men, 34.6%; women, 45.9%) in 2016 ([Table 3](#t3-ns-1836038-019){ref-type="table"}). Average annual cost per patient older than 65 years old was approximately 1.28 times to that of total patients of spinal diseases.

The average medical cost per visit was \$36.38 (41,660) among male patients, and \$31.44 (36,000) among female patients. Although the medical cost per visit for female patients was cheaper than that for male patients, female patients had higher expenditure because of more frequent visit to the clinic than male patients.

The number of claims, total medical costs, and amounts of copayment per 100,000 population are shown in [Table 5](#t5-ns-1836038-019){ref-type="table"} (the expenditure in KRW is shown in Supplementary [Table 1](#t1-ns-1836038-019){ref-type="table"}). Although the number of claims increased by 3.1%, the total medical cost increased by 23.5% over 5 years. Copayments also increased by 20.9% during the study period. An increase in medical cost per claim was estimated. In a comparison of the annual medical expenditure of inpatients and outpatients, the cost per outpatient visit increased by 18.3% over 5 years; however, that of inpatients decreased by 9.1%. The increment of medical expenditure over 5 years may be related to the increase in the cost of outpatient visits.

4. The Distribution of Medical Cost Stratified by Disease Code, Age, and sex
----------------------------------------------------------------------------

The total medical expenditure of spinal diseases per 100,000 population-year stratified by disease code is demonstrated in [Fig. 6](#f6-ns-1836038-019){ref-type="fig"}. The largest medical expenditure was spent on M51, followed by thoracic, thoracolumbar, and lumbosacral intervertebral disc disorders (M51), followed by dorsalgia (M54), other spondylosis including spinal stenosis and ankylosing hyperostosis (M48), cervical disc disorders (M50), spondylosis (M47), and other deforming dorsopathies including spondylolisthesis and recurrent atlantoaxial subluxation (M43). The medical cost of spondylopathy (M48) increased rapidly over 5 years and was close to that of M51 in 2016. The medical cost of radiculopathy (M54) showed a trend similar to M48, and comprised the highest medical expense in 2016.

The distribution of the medical expenses stratified by age, sex, and disease codes in 2016 is shown in [Fig. 7](#f7-ns-1836038-019){ref-type="fig"}. In female patients, dorsalgia (M54) accounted for the largest proportion of total medical costs for spinal diseases followed by spondylosis and stenosis (M48) and herniated disc disorders (M51). In male patients, herniated disc (M51) accounted for the largest proportion of total medical costs for spinal diseases followed by dorsalgia (M54), and spondylosis and stenosis (M48). Among women and men younger than 19 and 9 years of age, respectively, deforming dorsopathy (M40--43) had the highest medical expenses. In patients at least 60 years of age, other spondylosis including spinal stenosis (M48) accounted for the largest proportion of total medical costs. Other spondylosis (M48) had the largest expenditure even though patients were frequently diagnosed with disc herniation (M51).

DISCUSSION
==========

This study provides a comprehensive overview of the incidence and trends in spinal diseases in the ROK at the national level based on integrated data from the HIRA. The nationwide incidence of spinal diseases and medical costs increased continuously over the study period. While the incidence rate of spinal diseases was the highest among people in their 50s who mainly experienced disc herniation, the age-adjusted incidence rate was the highest among those in their 70s who mainly experienced spinal stenosis. M48 including spinal stenosis, which was frequent among older age groups, consumed more medical expenditure per patient.

The number of patients diagnosed with spinal diseases increased by 7.6% over the 5-year study period. As the age of population increased, the incidence of spinal diseases also increased and the peak incidence rate stratified by age was 42.6% in the 75--79 years age group. The reason for the increase in the number of patients may be related to the increase in the elderly population in the ROK because the age adjusted incidence rate of the population in ≥65 years old did not increase from 42.3% in 2012 to 40.9% in 2016, and proportion of the age group increased from 11.5% through 12.7% continuously as Korean society is aging. The population over 65 years of age in the ROK rapidly increased and made up 14.3% of the total population in 2018 \[[@b12-ns-1836038-019]\]. The World Health Organization and the United Nations define an "aging society" as one in which more than 7% of the population in ≥65 years old, an "aged society" as a society in which more than 14% of the population is ≥65 years old, and a "super-aged society" as a society in which more than 21% of the population is ≥65 years old \[[@b13-ns-1836038-019]\]. The ROK has become an aged society in 2018.

The number of claims increased by 3.1% over 5 years, with a 7.6% increase in the number of patients. The number of claims among male patients increased by 27.9% and 7.0% in both inpatient and outpatient clinics, and that of female patients increased by 26.3% and 0.5%, respectively. The reason for the mild increase in the number of claims may be due to the slight increase in claims among female outpatients who had the highest proportion of claims. They may have been hospitalized (as inpatients) and undergone surgical treatments instead of utilizing only outpatient services. Besides, the trend that male patients tend to have fewer hospital visits than female patients may be related with the result. Over the 5-year study period, the average cost per inpatient decreased by 9.1%, whereas the cost per outpatient increased by 18.3%. The reason for the increase in medical expenses was mainly due to +outpatient services. The reason for the increment in medical cost for outpatients may be related to pain interventions \[[@b14-ns-1836038-019]\]. Further prospective studies are needed on this topic to find out this relationship.

Although the ICD-10 code is used worldwide, the code system cannot clearly distinguish specific diseases of the spine and some diseases have multiple codes. Moreover, M54 including dorsalgia, coccygodynia, radiculopathy, and sciatica was a symptom related code, and was usually used as a preliminary diagnosis before diagnostic workup. Thus, M54 was hard to regard as a primary disease code and excluded from this analysis. The largest medical expenditure was on thoracic and lumbosacral intervertebral disc disorders (M51) followed by dorsalgia (M54), and other spondylosis including spinal stenosis (M48). The medical expenditure on M48 increased rapidly during the study period, which may be due to the increased number of patients and medical cost per claim. The majority of spinal diseases differed by age and sex. Among individuals younger than 19 years, the most common spinal disease was scoliosis (M41), and might have been adolescent idiopathic scoliosis. In that age group, deforming dorsopathy (M40--43) had the highest medical expenses, which may be related to corrective surgeries for deformities due to adolescent idiopathic scoliosis. In patients younger than 39 years, the most common disease was lumbar and thoracic disc herniation (M51) and male patients accounted for the higher proportion. Disc herniation among young men may be related with hard work, vigorous physical activity, and obligatory military service. Among patients older than 40 years, females accounted for the higher proportion. Among patients at least 60 years of age, other spondylosis including spinal stenosis (M48) accounted for the highest incidence and the largest proportion of total medical costs. Spinal stenosis among elderly women may be related with degenerative change due to long kitchen work and farm work \[[@b15-ns-1836038-019]\].

There are limitations that need to be acknowledged and addressed in the present study. The first limitation is with regards to the use of ICD-10 codes. ICD-10 codes are assigned for inpatient hospital diagnoses at discharge, and represent a patient's diagnostic and procedural events \[[@b11-ns-1836038-019]\]. However, studies utilizing ICD-10 codes in databases should be interpreted with caution, as their original purpose was not intended for research. Unfortunately, there is neither a specific term nor a specific diagnostic ICD-10 code to describe degenerative spinal diseases such as cervical spondylotic myelopathy, ossification of the posterior longitudinal ligament, and ossification of the ligamentum flavum \[[@b16-ns-1836038-019]\]. This has resulted in the inconsistent use of diagnostic terms when referring to patients with these diseases, and subsequently, has given rise to ambiguity in critically exploring diagnoses, interventions, and outcomes for this prevalent and disabling set of conditions. A previous study has questioned the accuracy of administrative data for capturing clinical diagnoses \[[@b17-ns-1836038-019]\].

The second limitation is the included population of this study. This study included only beneficiaries of NHIS, which is 97% of the total population in the ROK. The remaining 3% of the population was covered with the Medical Aids, and were applied totally different system from the beneficiaries of NHIS. Because their incidence and medical expenses were not disclosed to public, we analyzed the data from the beneficiaries of NHIS. Although this study did not include the entire population of the ROK, we think it would be more important to analyze the population of 97%, which is subject to common regulations by NHIS, for health policy formulation.

The third limitation is related to the accuracy of the medical expenditures to which the findings can be generalized. Among total medical costs comprising paid medical expenses by insurers, copayments, unpaid medical expenses by insurers, and pharmacy preparation costs, the unpaid expenses and pharmacy preparation costs were not included in the medical expenditure. Although these were a relatively small proportion of the total medical costs, estimation of the exact cost of medical expenditures need to be made with caution.

Finally, retrospective surveys obtain information directly from affected individuals but may be subject to recall bias. The claimsbased data used in our study may have enabled us to avoid this limitation; they are not dependent on individual reporting and only detect subjects whose physicians coded for back pain associated with a given episode of care \[[@b7-ns-1836038-019]\]. Prospective methods of data collection for spinal diseases are superior for determining incidence and associations between patient characteristics, medical costs, and specific diseases.

CONCLUSION
==========

This nationwide big data on spinal diseases from 2012 to 2016 in the ROK demonstrated increases in the incidence and medical expenditures due to spinal diseases. The reason of increase in the incidence and the expenses may be caused by increased population ≥60 years old as the Korean society is aging. M51 including lumbar disc herniation accounted for the highest incidence and the largest medical expenses in patients \<60 years old, and M48 including spinal stenosis did in patients ≥60 years old. As the population of the ROK continues to age, the incidence and medical expenditures of spondylosis and stenosis (M48) are also increasing. The social burden of spinal disease in elder patient needs to be prudently considered in health policy makers.
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SUPPLEMENTARY MATERIAL
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###### 

Supplementary Table 1 can be found via (<https://doi.org/10.14245/ns.1836038.019>).

![Average annual incidence of spinal diseases per 100,000 in the Republic of Korea from 2012 to 2016. The incidence increased in both male and female patients by 11.2% and 5.1%, respectively; the overall increase over the 5-year study period was 7.6%.](ns-1836038-019f1){#f1-ns-1836038-019}

![The incidence of spinal diseases per 100,000 population in 2016. (A) The overall incidence was the highest among those aged 55--59 years; the age-group shows 1,586 male and 2,483 female patients per 100,000 population. (B) The age-adjusted incidences (age-adjusted to the age distribution of the entire population in the Republic of Korea in 2016) increased with increasing age. In the population aged 70--79 years, the average number of patients was 36,206 (36.2%) in men and 48,953 (49.0%) in women. Approximately 42.6% of the age-group population experienced spinal diseases.](ns-1836038-019f2){#f2-ns-1836038-019}

![The average incidence of spinal diseases per 100,000 population stratified by disease code in the Republic of Korea from 2012 to 2016. The most common spinal disease code was dorsalgia (M54, red line), followed by thoracic, thoracolumbar, and lumbosacral intervertebral disc disorders (M51, pink line), other spondylosis including spinal stenosis and ankylosing hyperostosis (M48, black line), spondylosis (M47, blue line), cervical disc disorders (M50, navy line), other dorsopathy, not elsewhere classified (M53, brown line), and other deforming dorsopathies including spondylolisthesis and recurrent atlantoaxial subluxation (M43, light blue line). There were no substantial changes in the ranking of disease over the study period.](ns-1836038-019f3){#f3-ns-1836038-019}

![Distribution of patients with spinal diseases stratified by sex and diagnostic codes in the Republic of Korea in 2016. There were more male patients than female patients among those younger than 39 years; however, there were more female patients older than 40 years. Deformity (M41) was common among patients aged 0--19 years. Among those younger than 59 years, diagnostic codes M54 and M51, mainly diseases with disc herniation, were the most common regardless of sex. Among those older than 60 years, M54 and M48 including spinal stenosis was the most common code for both sexes.](ns-1836038-019f4){#f4-ns-1836038-019}

![The average annual medical costs of spinal disease per patient in the Republic of Korea from 2012 to 2016. The cost increased from \$216.66 (₩248,080) in 2012 to \$248.62 (₩284,660) in 2016. Over the 5-year study period, the expenditure increased by a total of 14.7%; it increased by 13.9% and 15.4% for male and female patients, respectively. ₩, Korean Won.](ns-1836038-019f5){#f5-ns-1836038-019}

![M51 (purple) accounted for the largest medical expenses, followed by M54 (red), M48 (black), M50 (navy), and M47 (blue). M48 (black) showed rapid increment and medical cost of M48 was close to that of M51 (purple) in 2016. M54 (red) also showed rapid increase similar to M48 (black), and surpassed M51 (purple) in 2016. ₩, Korean Won.](ns-1836038-019f6){#f6-ns-1836038-019}

![The distribution of medical costs associated with spinal diseases stratified by sex and diagnostic codes in the Republic of Korea in 2016. In total, the largest medical expenditure was on dorsalgia (M54), followed by other spondylosis including spinal stenosis and ankylosing hyperostosis (M48), and thoracic, thoracolumbar, and lumbosacral intervertebral disc disorders (M51). The ranking of medical expenditure did not exactly match the ranking of the number of patients. In patients aged 0--19 years, M43 and M41 including deformity accounted for the largest expenditure. Among those older than 60 years of age, M48, including spinal stenosis, it accounted for the highest expenditure for both sexes.](ns-1836038-019f7){#f7-ns-1836038-019}

###### 

Definition of spine disease

  Code^[a](#tfn1-ns-1836038-019){ref-type="table-fn"}^   Inclusion                                                                Code^[a](#tfn1-ns-1836038-019){ref-type="table-fn"}^   Exclusion
  ------------------------------------------------------ ------------------------------------------------------------------------ ------------------------------------------------------ --------------------------------------
  M40                                                    Kyphosis and lordosis                                                    Q76.2-4                                                Congenital kyphosis and lordosis
  M41                                                    Scoliosis                                                                                                                       
  M42                                                    Spinal osteochondrosis                                                   M96.                                                   Postprocedural kyphosis and lordosis
  M43                                                    Other deforming dorsopathies                                             Q76.3-4                                                Hemivertebra
                                                          - Spondylolisthesis                                                     Q76.1                                                  Klippel-Feil syndrome
                                                          - Recurrent atlantoaxial subluxation                                                                                           
  M45                                                    Ankylosing spondylitis                                                   Q76.4                                                  Lumbarization and sacralization
  M46                                                    Other inflammatory spondylopathies                                                                                              
  M47                                                    Spondylosis                                                              Q76.4                                                  Platyspondylisis
                                                          - Degeneration of facet joints                                          M80-1                                                  Spinal curvature in osteoporosis
  M48                                                    Other spondylopathies                                                    M88                                                    Paget disease of bone
                                                          - Spinal stenosis                                                                                                              
                                                          - Ankylosing hyperostosis                                                                                                      
  M49                                                    Spondylopathies in disease classified elsewhere                          M02.3                                                  Arthropathy in Reiter disease
                                                          - Tuberculosis                                                                                                                 
                                                          - Brucella                                                                                                                     
                                                          - Parasitic disease                                                                                                            
  M50                                                    Cervical disc disorders                                                  M35.2                                                  Behcet disease
  M51                                                    Thoracic, thoracolumbar, and lumbosacral intervertebral disc disorders                                                          
  M53                                                    Other dorsopathy, NEC                                                    M08.1                                                  Juvenile (ankylosing) spondylitis
                                                          - Cervicobrachial syndrome                                                                                                     
                                                          - Spinal instabilities                                                                                                         
  M54                                                    Dorsalgia                                                                G54.0                                                  Thoracic outlet syndrome
                                                          - Coccygodynia                                                                                                                 
                                                          - Radiculopathy                                                                                                                
                                                          - Sciatica                                                                                                                     

NEC, not elsewhere classified.

The International Classification of Diseases, Tenth Revision codes (ICD-10), 2016. World Health Organization. \[11\]

###### 

The number of patients in spinal disease per 100,000 population stratified by age and sex

  Age (yr)   2012      2013      2014      2015      2016                                              
  ---------- --------- --------- --------- --------- --------- --------- --------- --------- --------- ---------
  0--4       24.6      20.2      29.9      24.1      28.5      22.9      30.1      24.1      32.5      25.8
  5--9       44.6      38.1      42.9      37.3      44.4      38.3      42.2      36.0      45.3      38.6
  10--14     178.4     186.1     167.4     180.5     164.2     183.4     150.2     165.5     145.4     158.1
  15--19     377.1     347.7     371.5     354.0     401.4     389.6     397.8     378.4     405.8     377.9
  20--24     420.6     433.4     441.4     449.9     487.4     494.9     493.3     489.7     528.0     511.7
  25--29     628.0     621.3     616.7     602.2     648.9     617.4     639.0     603.0     660.8     632.2
  30--34     900.3     846.7     934.5     860.1     981.1     890.2     925.9     832.5     918.7     836.1
  35--39     1,014.9   1,020.9   1,017.4   981.8     1,047.7   988.2     1,044.4   960.0     1,100.3   1,010.2
  40--44     1,161.5   1,371.8   1,185.3   1,338.4   1,232.0   1,349.1   1,211.2   1,284.0   1,218.0   1,275.7
  45--49     1,194.2   1,711.9   1,186.7   1,649.4   1,263.2   1,705.0   1,256.8   1,655.2   1,318.6   1,699.9
  50--54     1,423.8   2,395.8   1,439.6   2,339.7   1,461.3   2,317.1   1,413.9   2,189.7   1,409.0   2,124.3
  55--59     1,274.8   2,129.0   1,322.5   2,153.3   1,436.3   2,290.0   1,477.8   2,332.4   1,586.0   2,483.5
  60--64     1,125.9   1,852.3   1,133.6   1,838.3   1,170.9   1,889.3   1,219.2   1,954.8   1,332.8   2,115.4
  65--69     1,069.6   1,867.5   1,059.7   1,796.3   1,117.2   1,843.1   1,134.2   1,840.3   1,189.3   1,913.1
  70--74     1,017.8   1,915.0   1,062.9   1,958.1   1,070.2   1,963.9   1,047.3   1,886.1   1,039.6   1,840.7
  75--79     653.1     1,351.9   699.7     1,418.9   757.3     1,515.0   784.0     1,544.6   822.0     1,600.1
  ≥ 80       382.8     965.0     420.6     1,035.1   468.2     1,127.2   515.3     1,218.8   571.6     1,319.5

###### 

Statistics of the population over 65 years of age

  Item                                                                                                                                                                                                               2012           2013           2014           2015           2016
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------- -------------- -------------- -------------- -------------- --------
  Annual incidence of spinal disease in the old^[a](#tfn2-ns-1836038-019){ref-type="table-fn"}^ per 100,000 population^[b](#tfn3-ns-1836038-019){ref-type="table-fn"}^                                Total          4,656          4,763          4,969          5,032          5,193
  M/F                                                                                                                                                                                                 3,148/6,183    3,262/6,282    3,433/6,522    3,509/6,572    3,650/6,749    
  Proportion of old patients^[a](#tfn2-ns-1836038-019){ref-type="table-fn"}^ in entire population in the Republic of Korea^[b](#tfn3-ns-1836038-019){ref-type="table-fn"}^                            Total          11.0%          11.5%          11.9%          12.3%          12.7%
  M/F                                                                                                                                                                                                 9.2%/12.8%     9.7%/13.3%     10.1%/13.8%    10.5%/14.1%    10.9%/14.5%    
  Annual incidence of spinal disease in the old^[a](#tfn2-ns-1836038-019){ref-type="table-fn"}^ per 100,000 population of the same age (≥ 65) group^[b](#tfn3-ns-1836038-019){ref-type="table-fn"}^   Total          42,289         41,484         41,639         40,831         40,897
  M/F                                                                                                                                                                                                 11,659/8,120   10,985/8,143   11,086/7,917   10,866/7,544   11,013/7,277   
  Proportion of medical expense of the old^[a](#tfn2-ns-1836038-019){ref-type="table-fn"}^ among the total patients with spinal diseases^[c](#tfn4-ns-1836038-019){ref-type="table-fn"}^              Total          38.6%          39.5%          40.1%          40.3%          41.2%
  M/F                                                                                                                                                                                                 32.2%/42.9%    33.0%/43.9%    33.5%/44.6%    33.8%/44.8%    34.6%/45.9%    
  Rate of medical cost per old patient with spinal disease compared to average medical cost of all patients with spinal diseases^[c](#tfn4-ns-1836038-019){ref-type="table-fn"}^                      Total          1.28           1.28           1.29           1.28           1.31
  M/F                                                                                                                                                                                                 1.2/1.23       1.2/1.26       1.21/1.25      1.2/1.27       1.23/1.28      

Patients older than 65 years old.

Denominator was both patients with spinal disease and the other population in the Republic of Korea.

Denominator was only patients diagnosed of spinal diseases.

###### 

The number of patients stratified by common disease code, age, and sex

  Sex      Age (yr)   Deforming dorsopathy (scoliosis^[a](#tfn5-ns-1836038-019){ref-type="table-fn"}^)   Spondylopathy (stenosis^[a](#tfn5-ns-1836038-019){ref-type="table-fn"}^)   Other dorsopathy (herniated disc^[a](#tfn5-ns-1836038-019){ref-type="table-fn"}^)                                 
  -------- ---------- ---------------------------------------------------------------------------------- -------------------------------------------------------------------------- ----------------------------------------------------------------------------------- --------- --------- --------- ---------
  Male     0--9       3,006                                                                              6,624                                                                      312                                                                                 133       90        58        9,147
           10--19     17,313                                                                             3,142                                                                      6,212                                                                               1,397     3,022     17,130    96,827
           20--29     6,447                                                                              5,148                                                                      20,044                                                                              6,761     19,022    76,968    193,408
           30--39     3,337                                                                              6,121                                                                      41,272                                                                              18,747    49,383    141,886   314,266
           40--49     2,334                                                                              8,539                                                                      66,141                                                                              42,975    89,721    164,384   372,499
           50--59     1,912                                                                              14,975                                                                     98,153                                                                              108,781   117,875   184,900   416,239
           60--69     1,578                                                                              17,878                                                                     103,422                                                                             168,294   79,828    145,780   345,341
           70--79     1,153                                                                              12,671                                                                     90,029                                                                              170,832   38,947    93,728    258,821
           ≥ 80       407                                                                                3,052                                                                      29,514                                                                              59,368    7,966     25,382    82,273
  Female   0--9       3,143                                                                              4,842                                                                      205                                                                                 70        58        65        7,407
           10--19     29,455                                                                             1,724                                                                      5,780                                                                               975       2,781     11,469    86,094
           20--29     10,786                                                                             2,927                                                                      19,446                                                                              4,616     19,493    50,079    198,424
           30--39     6,096                                                                              4,651                                                                      36,939                                                                              13,427    45,736    101,383   304,803
           40--49     4,751                                                                              10,949                                                                     77,436                                                                              48,370    109,007   174,698   450,954
           50--59     5,456                                                                              38,638                                                                     156,514                                                                             182,271   162,221   293,663   661,577
           60--69     4,773                                                                              46,190                                                                     177,667                                                                             301,635   100,896   247,322   570,388
           70--79     4,574                                                                              31,644                                                                     183,530                                                                             336,265   55,652    181,647   500,403
           ≥ 80       1,523                                                                              7,673                                                                      71,961                                                                              127,425   14,316    57,384    198,937

A representative common disease of each group.

Disease code of the International Classification of Diseases, Tenth Revision codes (ICD-10), 2016. World Health Organization. \[11\]

###### 

Number of claims and total medical cost per 100,000 population and mean copayment per each visit in the Republic of Korea from 2012 to 2016

  Service                                                                              Sex                                                                                  Item               2012          2013          2014          2015          2016      Change rate^[c](#tfn9-ns-1836038-019){ref-type="table-fn"}^
  ------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------ ------------------ ------------- ------------- ------------- ------------- --------- -------------------------------------------------------------
  Inpatient                                                                            Male                                                                                 Number of claims   990           1,086         1,260         1,217         1,266     27.9%
  Total cost of medical care service^[a](#tfn7-ns-1836038-019){ref-type="table-fn"}^   \$933,304                                                                            \$957,539          \$976,210     \$998,868     \$1,086,929   16.5%                   
  Mean copayment per visit^[b](#tfn8-ns-1836038-019){ref-type="table-fn"}^             \$221.70                                                                             \$206.37           \$181.38      \$190.61      \$199.01      -10.2%                  
  Female                                                                               Number of claims                                                                     1,359              1,453         1,657         1,634         1,717         26.3%     
  Total cost of medical care service^[a](#tfn7-ns-1836038-019){ref-type="table-fn"}^   \$1,280,500                                                                          \$1,298,574        \$1,324,041   \$1,358,381   \$1,495,316   16.8%                   
  Mean copayment per visit^[b](#tfn8-ns-1836038-019){ref-type="table-fn"}^             \$224.70                                                                             \$212.49           \$190.28      \$196.26      \$204.89      -8.8%                   
  Both                                                                                 Annual cost per one patient                                                          \$1,299.2          \$1,227.3     \$1,075.1     \$1,135.2     \$1,181.2     -9.1%     
  Outpatient                                                                           Male                                                                                 Number of claims   77,779        79,041        81,247        80,584        83,251    7.0%
  Total cost of medical care service^[a](#tfn7-ns-1836038-019){ref-type="table-fn"}^   \$1,708,471                                                                          \$1,825,329        \$1,997,184   \$2,110,039   \$2,260,911   32.3%                   
  Mean copayment per visit^[b](#tfn8-ns-1836038-019){ref-type="table-fn"}^             \$6.48                                                                               \$6.80             \$7.17        \$7.72        \$8.05        24.2%                   
  Female                                                                               Number of claims                                                                     136,559            134,958       137,961       133,566       137,206       0.5%      
  Total cost of medical care service^[a](#tfn7-ns-1836038-019){ref-type="table-fn"}^   \$2,681,180                                                                          \$2,775,211        3,007,798     \$3,101,778   \$3,309,188   23.4%                   
  Mean copayment per visit^[b](#tfn8-ns-1836038-019){ref-type="table-fn"}^             \$5.66                                                                               \$5.91             \$6.22        \$6.75        \$7.08        25.1%                   
  Both                                                                                 Annual cost per one patient                                                          \$145.2            \$150.9       \$159.5       \$166.2       \$171.7       18.3%     
  Total                                                                                                                                                                     Number of claims   108,240       108,190       110,981       108,419       111,645   3.1%
                                                                                       Total cost of medical care service^[a](#tfn7-ns-1836038-019){ref-type="table-fn"}^   \$3,299,428        \$3,426,512   \$3,650,696   \$3,782,456   \$4,074,150   23.5%     
                                                                                       Mean copayment per visit^[b](#tfn8-ns-1836038-019){ref-type="table-fn"}^             \$8.32             \$8.63        \$8.94        \$9.57        \$10.05       20.9%     

The standard unit of cost is United States dollars, and the table in terms of Korean won (₩) is in the appendix Table 1.

Sum of payment by both insurer and beneficiary excluding unpaid items designated by insurer and pharmacy preparation costs by pharmaceutical prescriptions.

Copayment, a payment made by a beneficiary at each visit in addition to that made by an insurer.

Change rate, a rate over 5 years from 2012 to 2016.
